Comparison of malnutrition in hemodialysis and peritoneal dialysis patients and its relationship with echocardiographic findings
Afsoon Emami Naini1, Alireza Karbalaie1, Mokhtar Abedini1, Gholamreza Askari2, Firouzeh Moeinzadeh1
1 Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Community Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Submission||26-Jun-2015|
|Date of Decision||29-Aug-2015|
|Date of Acceptance||09-May-2016|
|Date of Web Publication||01-Sep-2016|
Isfahan University of Medical Sciences, Isfahan
Source of Support: None, Conflict of Interest: None
Background: Malnutrition is common in patients with end-stage renal disease (ESRD) who on peritoneal dialysis (PD) or hemodialysis (HD). This study aimed to compare the frequency distribution of malnutrition in HD and PD patients and its relationship with echocardiographic findings. Materials and Methods: This is a case-control study. Using the simple random sampling, 109 patients were selected among HD and PD patients based on the inclusion criteria. HD and PD groups included 55 and 54 patients, respectively. The malnutrition-inflammation score (MIS) index was used to assess malnutrition. Echocardiography was performed by a cardiologist. All the data were analyzed by SPSS version 18. Results: In this study, 79.6% (43 patients) were in the PD group with MIS <9 (no malnutrition to mild malnutrition) and 20.4% (11 patients) with 9 ≤ MIS ≤ 18 suffered from moderate malnutrition. In the HD group, 72.7% (forty patients) had MIS < 9, 25.5% (14) had 9 ≤ MIS ≤ 18, and 1.8% (one patient) with MIS > 18 suffered from severe malnutrition (P = 0.74). There was no significant relationship between MIS and echocardiographic findings in PD patients (P > 0.05). In the HD group, there was no significant relationship between MIS and echocardiographic findings (P > 0.05), except for aortic and mitral valve insufficiencies (P < 0.05). Conclusion: The findings of this study show 27.3% of HD patients had moderate to severe malnutrition. There was a statistically significant relationship between MIS index and aortic and mitral valve insufficiencies in HD patients.
Keywords: Continuous ambulatory peritoneal dialysis, end-stage renal disease, hemodialysis, malnutrition-inflammation score
|How to cite this article:|
Naini AE, Karbalaie A, Abedini M, Askari G, Moeinzadeh F. Comparison of malnutrition in hemodialysis and peritoneal dialysis patients and its relationship with echocardiographic findings. J Res Med Sci 2016;21:78
|How to cite this URL:|
Naini AE, Karbalaie A, Abedini M, Askari G, Moeinzadeh F. Comparison of malnutrition in hemodialysis and peritoneal dialysis patients and its relationship with echocardiographic findings. J Res Med Sci [serial online] 2016 [cited 2020 Feb 20];21:78. Available from: http://www.jmsjournal.net/text.asp?2016/21/1/78/189695
| Introduction|| |
Malnutrition is common in patients with end-stage renal disease (ESRD) who on peritoneal dialysis (PD) or hemodialysis (HD). The causes of malnutrition in HD and PD patients include low energy intake induced by anorexia, loss of nutrients due to dialysis, dietary restriction before dialysis, increased protein catabolism and acidosis. ,, The need for protein increases in PD patients due to severe peritoneal protein loss which is aggravated due to peritoneal infections. ,,,, In addition to the foregoing, inflammation and inflammatory factors also play an important role in the development of malnutrition in these patients. Some complications of prolonged inflammatory process include protein loss, adipose and muscle atrophy, increased catabolism, oxidative stress, and atherosclerosis. ,,,, Following the deterioration of the nutritional status, ESRD results in inflammatory responses with various mechanisms such as decreased clearance of proinflammatory cytokines, release of oxidative substances such as free oxygen radicals and reduced intake of antioxidants such as Vitamin E. ,,,,, Recent studies have shown that patients suffering from malnutrition have a higher rate of mortality compared to well-nutritioned patients. ,,,,] The major causes of mortality in ESRD patients are cardiovascular complications. ,, The risk of cardiovascular diseases among HD patients with protein-energy malnutrition (PEM) is higher compared to well-nourished HD patients. Traditional risk factors for cardiovascular diseases such as a high body mass index (BMI) and serum total cholesterol cannot explain the high prevalence of cardiovascular diseases in HD patients with PEM.  The most probable mechanism of this complication is myocardial ischemia. Nevertheless, heart failure is an important cause of mortality and morbidity in ESRD patients. , The prevalence of hypertension, left ventricular hypertrophy, ischemic heart disease, and heart failure is higher in patients with chronic renal failure on dialysis. Their cardiovascular mortality is about 10-30 times more than normal populations. , In one study, the prevalence of some cardiovascular disease in ESRD patients includes 14% coronary artery disease, 19% angina pectoris, 31% cardiac failure, 7% dysrhythmia, and 8% peripheral vascular disease. On echocardiography 15% had systolic dysfunction, 32% left ventricular dilatation, and 74% left ventricular hypertrophy. ,,, According to above studies, cardiovascular complications have been reported in dialysis patients. However, no study has evaluated the relationship of echocardiographic findings and malnutrition in dialysis patients. Therefore, we compared the frequency distribution of malnutrition between hemodialysis and peritoneal dialysis patients and its relationship with echocardiographic findings.
| Materials and methods|| |
This case-control study was done in a dialysis center, both HD and continuous ambulatory PD, in 2011-2012 in Isfahan University of Medical Sciences, Iran. HD and PD patients during the study were included in the study. The exclusion criteria included: patients with severe infection during 1 month before our study, change of dialysis method, history of rheumatic heart disease, cardiomyopathy, and primary pulmonary hypertension were not included. A total of 109 participants were selected using the simple random sampling. HD and PD groups included 55 and 54 patients, respectively. Malnutrition-inflammation score (MIS) index was used for the evaluation of malnutrition. MIS consists of ten components, each with four levels of intensity, from 0 (normal) to 3 (severe). The ten components include dry weight change, dietary intake, gastrointestinal symptoms, work capacity, associated diseases, reduced fat stores or loss of subcutaneous fat, reduced muscle mass symptoms, BMI, serum albumin, and total iron-binding capacity levels. The sum of scores ranged from 0 (normal) to 30 (severe malnutrition). According to studies, the grading of severity of malnutrition according to MIS score is as follows:
- Lack of malnutrition to mild malnutrition: MIS <9
- Moderate malnutrition: MIS = 9-18
- Severe malnutrition: MIS >18.
Echocardiography was performed by a cardiologist by Ge vivid 3.
The patient's demographic information including age and sex along with their echocardiographic information such as ejection fraction, regurgitation of aortic, mitral, tricuspid, pulmonary valves, and MIS were recorded. All the data were analyzed by SPSS version 18.0 , Inc, Chicago, Ill., USA using descriptive statistics (mean and standard deviation of variables) and Chi-square tests to compare MIS based on the type of dialysis and echocardiographic findings and Mann-Whitney U-test. P < 0.05 was considered statistically significant.
| Results|| |
Among the 109 participants, 54 patients were in the PD group. Thirty-nine patients (72.2%) were men and 15 (27.8%) were women with a mean age of 59.77 ± 1.33. In addition, 55 patients were in the HD group. Thirty-five patients (63.60%) were men and 20 (36.4%) were women with the mean age of 54.21 ± 1.30.
[Table 1] shows the frequency distribution of MIS in PD and HD groups and compares them.
|Table 1: The frequency distribution of the malnutrition-inflammation score index|
Click here to view
There was no significant difference between the two groups in terms of the frequency distribution of malnutrition indicators (MIS) (P > 0.05).
The relationship between the type of dialysis and echocardiographic findings were analyzed using Chi-squared test.
In the HD group, there was no significant relationship between MIS and echocardiographic findings (P > 0.05), except for aortic and mitral valve insufficiencies (P < 0.05).
[Table 2] indicates that there was no significant relationship between MIS and echocardiographic findings in PD patients (P > 0.05).
|Table 2: The relationship between malnutrition-inflammation score and echocardiographic findings in hemodialysis and peritoneal dialysis groups|
Click here to view
| Discussion|| |
PEM and inflammation are common and usually concurrent in maintenance dialysis patients. Many factors that appear to lead to these two conditions overlap, as do assessment tools and such criteria for detecting them as hypoalbuminemia. Both these conditions are related to poor dialysis outcome. Low appetite and a hypercatabolic state are among common features. PEM in dialysis patients has been suggested to be secondary to inflammation; however, the evidence is not conclusive, and an equicausal status or even opposite causal direction is possible. Hence, malnutrition inflammation score (MIS) is an appropriate term. Possible causes of MIS include comorbid illnesses, oxidative and carbonyl stress, nutrient loss through dialysis, anorexia and low nutrient intake, uremic toxins, decreased clearance of inflammatory cytokines, volume overload, and dialysis-related factors. MIS is believed to be the main cause of erythropoietin hyporesponsiveness, high rate of cardiovascular atherosclerotic disease, decreased the quality of life and increased mortality and hospitalization in dialysis patients. Because MIS leads to a low BMI, hypocholesterolemia, hypocreatininemia, and hypohomocysteinemia, a "reverse epidemiology" of cardiovascular risks can occur in dialysis patients. Therefore, obesity, hypercholesterolemia, and increased blood levels of creatinine and homocysteine appear to be protective and paradoxically associated with a better outcome. There is no consensus about how to determine the degree of severity of MIS or how to manage it. Several diagnostic tools and treatment modalities are discussed. Successful management of MIS may ameliorate the cardiovascular epidemic and poor outcome in dialysis patients. ,,, In the comparison between the frequency distribution of MIS in the participants of PD and HD groups, despite the 1.8% participants with severe malnutrition in the HD group, no statistically significant differences was observed. This indicates that MIS was the same in these two groups. Although it was calculated in this study that there is no significant relationship between MIS and echocardiographic findings (ejection fraction, aortic, mitral, pulmonary, and tricuspid valve insufficiencies) in PD participants, there was a significant relationship between MIS and echocardiographic findings and aortic and mitral valve insufficiencies, and other echocardiographic findings had no significant relationship. The study by Liu et al. who evaluated peripheral vascular disease in HD patients, found that the rate of cardiac death, death due to infection, peripheral vascular disease, and cardiovascular hospitalization was higher in them compared to healthy participants.  In another study, by Pecoits-Filho et al., it was found that the risk of diastolic heart failure was higher in patients with chronic renal failure compared to the general population. 
| Conclusion|| |
It can be concluded that if severe malnutrition aggravates in HD patients, the chance of a significant relationship between MIS and echocardiographic findings increases.
Finally, this project is recommended to be conducted with a lager sample size to repeat these results so that they are proven with greater certainty.
We would like to express thanks for Isfahan Kidney Diseases Research Center.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| Authors Contribution|| |
- AEN contributed in the conception of the work, conducting the study, revising the draft, approval of the final version of the manuscript, and agreed for all aspects of the work.
- AK contributed in the conception of the work, collecting data, conducting the study, revising the draft, approval of the final version of the manuscript, and agreed for all aspects of the work.
- MA contributed in the conception of the work, conducting the study, revising the draft, approval of the final version of the manuscript, and agreed for all aspects of the work
- GA contributed in the conception of the work, revising the draft, approval of the final version of the manuscript, and agreed for all aspects of the work.
- FM contributed in the conception of the work, analyzing data, revising the draft, approval of the final version of the manuscript, and agreed for all aspects of the work.
| References|| |
Bossola M, Muscaritoli M, Tazza L, Giungi S, Tortorelli A, Rossi Fanelli F, et al.
Malnutrition in hemodialysis patients: What therapy? Am J Kidney Dis 2005;46:371-86.
Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000;15:953-60.
Mardani M, Rezapour P, Baba H, Balavar S, Naghdi N. The nutritional status of hemodialysis patients admitted to Khoramabad′s Shohadie Ashaier hospital, Korramabad, Iran. J Prev Epidemiol 2016;1:e09.
Diamond SM, Henrich WL. Nutrition and peritoneal dialysis. In: Mitch WE, Klahr S, editors. Nutrition and the Kidney. Boston: Little, Brown; 1988. p. 198-223.
Fallahzadeh MH, Fallahzadeh MA. On the occasion of world kidney day 2016; renal disease in children. Acta Persica Pathophysiol 2016;1:e04.
Marckmann P. Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 1988;29:75-8.
Amiri M, Hosseini SM. Diabetes mellitus type 1; is it a global challenge? Acta Epidemioendocrinol 2016;1:e02.
Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, et al.
Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 1991;17:462-71.
Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002;17:1085-92.
Dehghan Shahreza F. Vascular protection by herbal antioxidants; recent views and new concepts. J Prev Epidemiol 2016;1:e05.
Dehghan Shahreza F. From oxidative stress to endothelial cell dysfunction. J Prev Epidemiol 2016;1:e04.
Yýlmaz MY. The causes of the infl ammation and possible therapeutic options in dialysis patients. Gulhane Med J 2007;49:271-6.
Afshar R, Sanavi S, Izadi-Khah A. Assessment of nutritional status in patients undergoing maintenance hemodialysis: A single-center study from Iran. Saudi J Kidney Dis Transpl 2007;18:397-404.
Khazaei M. Adipokines and their role in chronic kidney disease. J Nephropharmacol 2016;5:69-70.
Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993;8:1094-8.
Duerksen DR, Yeo TA, Siemens JL, O′Connor MP. The validity and reproducibility of clinical assessment of nutritional status in the elderly. Nutrition 2000;16:740-4.
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 2003;42:864-81.
Lala MA, Nazar CM, Lala HA, Singh JK. Interrelation between blood pressure and diabetes. J Ren Endocrinol 2015;1:e05.
Lal AK, de Biasi AR, Alexander S, Rosenthal DN, Sutherland SM. End-stage renal disease and cardiomyopathy in children: Cardiac effects of renal transplantation. Transplantation 2012;93:182-7.
Dehghan Shahreza F. Mechanistic impact of renal tubular cell protection by antioxidants. Ann Res Antioxid 2016;1:e06.
Galli EG, Taietti C. Home peritoneal ultrafiltration in the treatment of chronic heart failure. G Ital Nefrol 2011;28:506-13.
Nazar CM, Bashir F, Izhar S, Ahmed SA. Does frequent hemodialysis regimen result in regression of left ventricular mass compared to conventional hemodialysis? J Nephropharmacol 2015;4:37-41.
Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al.
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-15.
Momeni A. Cardiovascular complications of renal failure in hemodialysis patients. Ann Res Dial 2016;1:e05.
Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al
. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-92.
Nasri H, Ardalan MR, Rafieian-Kopaei M. On the occasion of world hypertension day 2014. J Parathyr Dis 2014;2:5-6.
Rastegari F. The healthy diet for cardiovascular disease. Acta Persica Pathophysiol 2016;1:e02.
Hajian S. Positive effect of antioxidants on immune system. Immunopathol Persa 2015;1:e02.
Roozbeh J, Sagheb MM, Vafaie E. The association between blood pressure level and serum uric acid concentration in hemodialysis patients. J Nephropathol 2015;4:85-90.
Pecoits-Filho R, Bucharles S, Barberato SH. Diastolic heart failure in dialysis patients: Mechanisms, diagnostic approach, and treatment. Semin Dial 2012;25:35-41.
Ghaderian SB, Hayati F, Shayanpour S, Beladi Mousavi SS. Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev 2015;4:28-33.
Liu T, Liang KV, Rosenbaum A, Stephenson R, Pike F, Weissfeld L. Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO Study. Nephrol Dial Transplant 2012;27(7):2929-36.
[Table 1], [Table 2]
|This article has been cited by|
||Assessment of nutritional status in the maintenance of haemodialysis patients: a cross-sectional study from Palestine
| ||Ali M. Omari,Leen S. Omari,Hazar H. Dagash,Waleed M. Sweileh,Nehal Natour,Sa’ed H. Zyoud |
| ||BMC Nephrology. 2019; 20(1) |
|[Pubmed] | [DOI]|
||The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients
| ||Zhigui Zheng,Jianguo Chen,Dongyuan He,Yuankai Xu,Lili Chen,Ting Zhang |
| ||International Urology and Nephrology. 2019; |
|[Pubmed] | [DOI]|
||New-Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis—A Review
| ||Rajashri Yarragudi,Alois Gessl,Andreas Vychytil |
| ||Therapeutic Apheresis and Dialysis. 2019; |
|[Pubmed] | [DOI]|
||Fushen Granule, A Traditional Chinese Medicine, ameliorates intestinal mucosal dysfunction in peritoneal dialysis rat model by regulating p38MAPK signaling pathway
| ||Chen Jiang,Wei Lin,Lingyun Wang,Yang Lv,Yu Song,Xin Chen,Hongtao Yang |
| ||Journal of Ethnopharmacology. 2019; : 112501 |
|[Pubmed] | [DOI]|